Clinical Trial Update: Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis [Phase 2]

View source ↗

Summary

A Phase 2 efficacy study evaluating three concentrations of SAR 1118 in allergic conjunctivitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• SAR 1118

Snippet

Sponsor: Shire | Conditions: Allergic Conjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2017-02-24